Original paper
Synergistic effects of piperlongumine and gemcitabine against KRAS mutant lung cancer
Abstract
To determine the combined efficacy of piperlongumine and gemcitabine for treatment of KRAS mutant lung cancer.The cell growth inhibition of piperlongumine, gemcitabine, and piperlongumine plus gemcitabine was measured by Cell Counting Kit‑8 assay and the combination index was calculated. In addition, the combined effects of piperlongumine and gemcitabine on cell apoptosis, reactive oxygen species (ROS) contents, and microtubule-associated...
Paper Details
Title
Synergistic effects of piperlongumine and gemcitabine against KRAS mutant lung cancer
Published Date
Jun 9, 2020
Journal
Volume
107
Issue
2
Pages
119 - 124
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History